Results 31 to 40 of about 3,884 (198)

Epidemiology of Melanoma in the Czech Republic in East Bohemia in the Period 2002–2017 and the Effect of the Annual Sunshine Exposure

Acta Medica, 2020
Aim: The evaluation of the trend in the occurrence of melanoma nodulare, melanoma superficiale, lentigo maligna and melanoma in situ in the period of 2002–2017 in East Bohemia region in the Czech Republic.
Jarmila Čelakovská, Josef Bukač, Lenka Čáková, Marie Šimková, Eva Jandová   +4 more
doaj   +1 more source

Lentigo Maligna Melanoma

Journal of Cutaneous Medicine and Surgery
Puckett Y, Geist R, Chen CSJ.
europepmc   +3 more sources

Follikulotropismus bei Lentigo maligna und Lentigo‐maligna‐Melanom im Kopf‐Hals‐Bereich

, 2021
Lentigo maligna (LM) und das Lentigo maligna-Melanom (LMM) sind Histotypen des Melanoms, die in Hautarealen mit kumulativer Schädigung durch Sonneneinstrahlung entstehen. Atypische Melanozyten in den Haarfollikeln (Follikulotropismus) sind ein typisches
Massi, Daniela, Cinotti, Elisa, Misciali, Cosimo, Mandel, Victor Desmond, Shaniko Kaleci, Rubegni, Pietro, Francesca Farnetani, Stanganelli, Ignazio, Kaleci, Shaniko, Scarfì, Federica, Farnetani, Francesca, Emi Dika, Dika, Emi, Perrot, Jean Luc, Francesca Di Tullio, Tullio, Francesca Di, Cosimo Misciali, Vincenzo De Giorgi, Martina Lambertini, Pellacani, Giovanni, Ignazio Stanganelli, Chester, Johanna, De Giorgi, Vincenzo, Giovanni Pellacani, Elisa Cinotti, Pietro Rubegni, Patrizi, Annalisa, Lambertini, Martina, Jean Luc Perrot, Annalisa Patrizi, Daniela Massi, Johanna Chester, Federica Scarfì, Victor Desmond Mandel   +33 more
core   +1 more source

Ten-year Follow-up Study of Grenz Ray Treatment for Lentigo Maligna and Early Lentigo Maligna Melanoma

Acta Dermato-Venereologica, 2020
Radiotherapy is often used to treat lentigo maligna. However, the long-term efficacy and safety of radiotherapy approaches have not been thoroughly evaluated.
Iara R.T. Drakensjö, Einar Rosen, Margareta Frohm Nilsson, Ada Girnita   +3 more
doaj   +1 more source

Change in lentigo maligna score assessed by in vivo reflectance confocal microscopy after one month of imiquimod treatment for lentigo maligna management

, 2021
Supplemental materials : Figure 1 : Lentigo Maligna before Imiquimod treatment. Confocal Microscopy mosaic images at the dermoepidermal junction.
Soenen, A (via Mendeley Data)
core   +2 more sources

Rapid recurrence of Lentigo Maligna Melanoma – A case report

JPRAS Open, 2017
Lentigo Maligna Melanoma (LMM) is a slow-growing variant of melanoma arising in a premalignant lesion (LM), which tends to appear on the sun-exposed skin of elderly people.
A. Abdaal, R.D. Price, A.J. Durrani
doaj   +1 more source

Progression to invasive melanoma frommalignant melanoma in situ, lentigo maligna type

, 2017
We have previously hypothesized that lesions that have been termed lentigo maligna can be divided into 2 categories: 1 represents a pigmented lesion that is a precursor to melanoma, and the other melanoma in situ.
Tannous, Zeina, Duncan, Lyn M., Lerner, Lisa H., Mihim, Martin C., Flotte, Thomas   +4 more
core   +1 more source

Lentigo maligna mimicking invasive melanoma in Mohs surgery: a case report [v1; ref status: indexed, http://f1000r.es/2mp]

F1000Research, 2014
Lentigo maligna is a lentiginous proliferation of atypical melanocytes confined to the epidermis, typically on chronically sun-damaged skin. Following biopsy and exclusion of invasive disease, therapy may involve Mohs surgery, topical treatment or ...
Teresa Tsakok, Nisith Sheth, Alistair Robson, Catherine Gleeson, Raj Mallipeddi   +4 more
doaj   +1 more source

Amelanotic Melanoma Treated as Fungal Infection for Years

Case Reports in Dermatological Medicine, 2022
This study describes a case of amelanotic lentigo maligna melanoma in a 69-year-old female that had been growing for approximately 5 years. The asymptomatic lesion had been previously diagnosed and treated as a fungal skin infection, an inflammatory rash,
Guilherme Kuceki, Dekker C. Deacon, Aaron M. Secrest   +2 more
doaj   +1 more source

Immune thrombocytopenic purpura: A rare side effect in a patient treated with Imiquimod for lentigo maligna

JPRAS Open, 2017
Topical Imiquimod is increasingly used in the treatment of lentigo maligna (LM) for patients not suitable or willing for surgery. It acts as an immune response modifier and is recommended for use with caution in patients with autoimmune disorders.
E.A. Whatling, K. Balghari, B.W.E.M. Powell   +2 more
doaj   +1 more source